Literature DB >> 30950777

Psychedelic-Assisted Group Therapy: A Systematic Review.

Alexander Trope1, Brian T Anderson1,2, Andrew R Hooker3, Giancarlo Glick4, Christopher Stauffer1,2, Joshua D Woolley1,2.   

Abstract

Contemporary research with classic psychedelic drugs (e.g., lysergic acid diethylamide (LSD) and psilocybin) is indebted to the twentieth-century researchers and clinicians who generated valuable clinical knowledge of these substances through experimentation. Several recent reviews that highlight the contributions of this early literature have focused on psychedelic-assisted individual psychotherapy modalities. None have attempted to systematically identify and compile experimental studies of psychedelic-assisted group therapy. In therapeutic settings, psychedelics were often used to enhance group therapy for a variety of populations and clinical indications. We report on the results of a systematic review of the published literature in English and Spanish on psychedelic-assisted group therapies. Publications are characterized by their clinical approach, experimental method, and clinical outcomes. Given the renewed interest in the clinical use of psychedelic medicines, this review aims to stimulate hypotheses to be tested in future research on psychedelic-assisted psychotherapy, group process, and interpersonal functioning.

Entities:  

Keywords:  LSD; Psychedelic; group therapy; hallucinogen; psilocybin; psychotherapy

Mesh:

Substances:

Year:  2019        PMID: 30950777      PMCID: PMC6650145          DOI: 10.1080/02791072.2019.1593559

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  25 in total

1.  Permissive group therapy with lysergic acid diethylamide.

Authors:  A M SPENCER
Journal:  Br J Psychiatry       Date:  1963-01       Impact factor: 9.319

2.  Use of d-lysergic acid diethylamide in the treatment of alcoholism.

Authors:  N CHWELOS; D B BLEWETT; C M SMITH; A HOFFER
Journal:  Q J Stud Alcohol       Date:  1959-09

3.  Using the CORE-R battery in group psychotherapy.

Authors:  Bernhard Strauss; Gary M Burlingame; Bianca Bormann
Journal:  J Clin Psychol       Date:  2008-11

4.  Three-level multilevel growth models for nested change data: a guide for group treatment researchers.

Authors:  Giorgio A Tasca; Vanessa Illing; Anthony S Joyce; John S Ogrodniczuk
Journal:  Psychother Res       Date:  2009-07

Review 5.  Psychiatry & the psychedelic drugs. Past, present & future.

Authors:  James J H Rucker; Jonathan Iliff; David J Nutt
Journal:  Neuropharmacology       Date:  2017-12-25       Impact factor: 5.250

6.  A controlled study of lysergide in the treatment of alcoholism. 1. The effects on drinking behavior.

Authors:  R G Smart; T Storm; E F Baker; L Solursh
Journal:  Q J Stud Alcohol       Date:  1966-09

7.  Outcome differences between individual and group formats when identical and nonidentical treatments, patients, and doses are compared: A 25-year meta-analytic perspective.

Authors:  Gary M Burlingame; Jyssica D Seebeck; Rebecca A Janis; Kaitlyn E Whitcomb; Sarah Barkowski; Jenny Rosendahl; Bernhard Strauss
Journal:  Psychotherapy (Chic)       Date:  2016-12

8.  Role of the 5-HT2A Receptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study.

Authors:  Katrin H Preller; Leonhard Schilbach; Thomas Pokorny; Jan Flemming; Erich Seifritz; Franz X Vollenweider
Journal:  J Neurosci       Date:  2018-03-19       Impact factor: 6.167

9.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

Review 10.  Methodological issues of human experimental research with hallucinogens.

Authors:  E Gouzoulis-Mayfrank; F Schneider; J Friedrich; M Spitzer; B Thelen; H Sass
Journal:  Pharmacopsychiatry       Date:  1998-07       Impact factor: 5.788

View more
  11 in total

Review 1.  Combinatorial approaches for treating neuropsychiatric social impairment.

Authors:  Don Wei; Sherab Tsheringla; James C McPartland; A Z A Stephen Azariah Allsop
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-07-11       Impact factor: 6.671

2.  Psychedelic Group Therapy.

Authors:  Peter Gasser
Journal:  Curr Top Behav Neurosci       Date:  2022

3.  Foundations for Training Psychedelic Therapists.

Authors:  Janis Phelps; James Henry
Journal:  Curr Top Behav Neurosci       Date:  2022

4.  Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.

Authors:  Brian T Anderson; Alicia Danforth; Prof Robert Daroff; Christopher Stauffer; Eve Ekman; Gabrielle Agin-Liebes; Alexander Trope; Matthew Tyler Boden; Prof James Dilley; Jennifer Mitchell; Joshua Woolley
Journal:  EClinicalMedicine       Date:  2020-09-24

5.  The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.

Authors:  Tomas Frymann; Sophie Whitney; David B Yaden; Joshua Lipson
Journal:  Front Psychol       Date:  2022-05-23

Review 6.  Psychedelics and Other Psychoplastogens for Treating Mental Illness.

Authors:  Maxemiliano V Vargas; Retsina Meyer; Arabo A Avanes; Mark Rus; David E Olson
Journal:  Front Psychiatry       Date:  2021-10-04       Impact factor: 4.157

Review 7.  Psychedelic integration: An analysis of the concept and its practice.

Authors:  Geoff J Bathje; Eric Majeski; Mesphina Kudowor
Journal:  Front Psychol       Date:  2022-08-04

8.  The influence of ceremonial settings on mystical and challenging experiences occasioned by ayahuasca: A survey among ritualistic and religious ayahuasca users.

Authors:  Alexandre Augusto de Deus Pontual; Luís Fernando Tófoli; Clarissa Mendonça Corradi-Webster; Kim van Oorsouw; Alicia Raquel Osuna Delgado; Johannes G Ramaekers
Journal:  Front Psychol       Date:  2022-07-15

9.  Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.

Authors:  Maggie Kamila Kiraga; Kim P C Kuypers; Malin Vedoy Uthaug; Johannes G Ramaekers; Natasha Leigh Mason
Journal:  Front Psychiatry       Date:  2022-07-07       Impact factor: 5.435

10.  Relational Processes in Ayahuasca Groups of Palestinians and Israelis.

Authors:  Leor Roseman; Yiftach Ron; Antwan Saca; Natalie Ginsberg; Lisa Luan; Nadeem Karkabi; Rick Doblin; Robin Carhart-Harris
Journal:  Front Pharmacol       Date:  2021-05-19       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.